MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clim.2022.109187

Медицинская библиотека · Clinical immunology (Orlando, Fla.) · 2022

Could Osteopontin be a useful biomarker in the diagnosis and severity assessment of osteoarthritis? A systematic review and meta-analysis of recent evidence.

Abdelnaby Ramy, Sonbol Yousef Tarek, Dardeer Khaled T, ELgenidy Anas, Ebrahim Mohamed Ayman, Elmenawi Khaled Abdelmoneim, Abdallah Alshaimaa Abdallah, Ballut Osama Omar, Metwally Sara Ahmed, Arafat Mennatullah Shaker, Elsayed Mohamed, Abouelhamd Ahmed Mahmoud, Farahat Ramadan Abdelmoez, Karkour Ali M, Mohamed Khaled Ashraf, Rauen Thomas

МетаанализСистематический обзорСтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Osteoarthritis (OA) patients demonstrated higher Osteopontin (OPN) plasma, serum, and synovial fluid concentrations than healthy individuals. In the present study, we aimed to investigate whether OPN could be used as a diagnostic or prognostic marker for OA symptom/disease severity.

METHODS

Using Web of Science, PubMed, Scopus, and Embase, we conducted a systematic review and meta-analysis of studies that measured OPN levels in OA patients' plasma, serum, or synovial fluid. After setting the eligibility criteria, data extraction, and quality assessment of the identified studies, we performed statistical analysis using Revman 5.4 and Open Meta analyst.

RESULTS

OPN has been found to be associated with advanced knee joint damage in OA patients. In addition, higher expression of OPN is thought to be associated with disease progression. Nevertheless, further studies should examine the role of other markers of chronic bone damage, such as leptin and sclerostin. This systematic review and meta-analysis included 14 studies with a total of 776 cases and 530 controls. OPN was significantly elevated in osteoarthritis patients' plasma, serum, and synovial fluid samples, with significant heterogeneity between studies.

CONCLUSION

We recommend that OPN plasma and synovial fluid levels be measured as a diagnostic and prognostic marker to determine the severity of OA symptoms.

Для цитирования: Abdelnaby Ramy, Sonbol Yousef Tarek, Dardeer Khaled T, ELgenidy Anas, Ebrahim Mohamed Ayman, Elmenawi Khaled Abdelmoneim, Abdallah Alshaimaa Abdallah, Ballut Osama Omar, Metwally Sara Ahmed, Arafat Mennatullah Shaker, Elsayed Mohamed, Abouelhamd Ahmed Mahmoud, Farahat Ramadan Abdelmoez, Karkour Ali M, Mohamed Khaled Ashraf, Rauen Thomas. Could Osteopontin be a useful biomarker in the diagnosis and severity assessment of osteoarthritis? A systematic review and meta-analysis of recent evidence.. Clinical immunology (Orlando, Fla.). 2022. DOI: 10.1016/j.clim.2022.109187.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.